Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| Rash | x | x | x | x | ||
| Folliculitis | x | x | x | x | ||
| Hypertrichosis | x | x | x | x | ||
| Miliaria | x | x | x | x | ||
| Paraesthesia | x | x | ||||
| Pruritus | x | x | x | |||
| Telangiectasia | x | x | ||||
| Erythema | x | x | x | x | ||
| Urticaria | x | |||||
| Skin atrophy | x | x | x | x | ||
| Dry skin | x | x | x | x | ||
| Skin striae | x | x | x | x | ||
| Allergic contact dermatitis | x | x | x | x | ||
| Leukoderma | x | x | x | x | ||
| Acneiform eruption | x | x | x | x | ||
| Dermatitis perioral | x | x | x | x | ||
| Secondary infection | x | x | x | x | ||
| Stinging | x | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||
|---|---|---|---|---|---|---|
| Skin disorder | x | x | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |